Chromadex Corp CDXC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
3.88quote price arrow up+0.10 (+2.65%)
Volume
701
Close
3.78quote price arrow up+0.02 (+0.53%)
Volume
121,474
52 week range
1.25 - 4.65
Loading...
  • Open3.80
  • Day High3.92
  • Day Low3.71
  • Prev Close3.76
  • 52 Week High4.65
  • 52 Week High Date04/05/24
  • 52 Week Low1.25
  • 52 Week Low Date10/23/23

Key Stats

  • Market Cap285.48M
  • Shares Out75.52M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta1.97
  • YTD % Change164.34

KEY STATS

  • Open3.80
  • Day High3.92
  • Day Low3.71
  • Prev Close3.76
  • 52 Week High4.65
  • 52 Week High Date04/05/24
  • 52 Week Low1.25
  • 52 Week Low Date10/23/23
  • Market Cap285.48M
  • Shares Out75.52M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta1.97
  • YTD % Change164.34

RATIOS/PROFITABILITY

  • EPS (TTM)-0.07
  • P/E (TTM)-57.36
  • Fwd P/E (NTM)-378.00
  • EBITDA (TTM)-4.543M
  • ROE (TTM)-17.29%
  • Revenue (TTM)83.57M
  • Gross Margin (TTM)60.76%
  • Net Margin (TTM)-5.91%
  • Debt To Equity (MRQ)0.08%

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Chromadex Corp

 

Content From Our Affiliates

Profile

MORE
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients...
Frank Jaksch Jr.
Chairman of the Board
Robert Fried
Chief Executive Officer, Director
Brianna Gerber
Chief Financial Officer
Address
10900 Wilshire Blvd, Suite 600
Los Angeles, CA
90024
United States

Top Peers

SYMBOLLASTCHG%CHG
ALIM
Alimera Sciences Inc
3.65+0.17+4.89%
AQST
Aquestive Therapeutics Inc
3.52+0.24+7.32%
OPTN
OptiNose Inc
1.01+0.13+15.09%
ESPR
Esperion Therapeutics Inc
2.08+0.02+0.97%
HROW
Harrow Inc
10.38-0.26-2.44%